Literature DB >> 22460439

Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient.

Tomoki Kawai1, Megumu Saito, Ryuta Nishikomori, Takahiro Yasumi, Kazushi Izawa, Tomohiko Murakami, Shigefumi Okamoto, Yasuko Mori, Noriko Nakagawa, Kohsuke Imai, Shigeaki Nonoyama, Taizo Wada, Akihiro Yachie, Katsuyuki Ohmori, Tatsutoshi Nakahata, Toshio Heike.   

Abstract

Reversion mosaicism is increasingly being reported in primary immunodeficiency diseases, but there have been few cases with clinically improved immune function. Here, a case is reported of X-linked severe combined immunodeficiency (SCID-X1) with multiple somatic reversions in T cells, which restored sufficient cell-mediated immunity to overcome viral infection. Lineage-specific analysis revealed multiple reversions in T cell receptor (TCR) αβ+ and TCRγδ+ T cells. Diversity of the TCRVβ repertoire was comparable to normal and, furthermore, mitogen-induced proliferation of the patient's T cells was minimally impaired compared to healthy controls. In vivo and in vitro varicella antigen-specific T cell responses were comparable to those of healthy controls, although a reduced level of T cell receptor excision circles suggested that recent thymic output was low. During long-term evaluation of the patient's immunologic status, both the number of CD4+ and CD8+ T cells and T cell proliferation responses were stable and the patient remained healthy. This case demonstrates that multiple but restricted somatic reversions in T cell progenitors can improve the clinical phenotype of SCID-X1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460439     DOI: 10.1007/s10875-012-9684-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

Authors:  H Kamiya; T Ihara; A Hattori; T Iwasa; M Sakurai; T Izawa; A Yamada; M Takahashi
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.

Authors:  V Stephan; V Wahn; F Le Deist; U Dirksen; B Broker; I Müller-Fleckenstein; G Horneff; H Schroten; A Fischer; G de Saint Basile
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

3.  Improved splice site detection in Genie.

Authors:  M G Reese; F H Eeckman; D Kulp; D Haussler
Journal:  J Comput Biol       Date:  1997       Impact factor: 1.479

4.  T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation.

Authors:  T Ariga; N Oda; K Yamaguchi; N Kawamura; H Kikuta; S Taniuchi; Y Kobayashi; K Terada; H Ikeda; M S Hershfield; K Kobayashi; Y Sakiyama
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

5.  Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency.

Authors:  C Tassara; A E Pepper; J M Puck
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

6.  Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease.

Authors:  J W Sleasman; T O Harville; G B White; J F George; D J Barrett; M M Goodenow
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

Review 7.  In vivo reversion to normal of inherited mutations in humans.

Authors:  R Hirschhorn
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

8.  X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.

Authors:  Ryuta Nishikomori; Hiroshi Akutagawa; Kyoko Maruyama; Mami Nakata-Hizume; Katsuyuki Ohmori; Kazunori Mizuno; Akihiro Yachie; Takahiro Yasumi; Takashi Kusunoki; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

9.  Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.

Authors:  Kay Sadaoka; Shigefumi Okamoto; Yasuyuki Gomi; Takeshi Tanimoto; Toyokazu Ishikawa; Tetsushi Yoshikawa; Yoshizo Asano; Koichi Yamanishi; Yasuko Mori
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

10.  Primary immunodeficiency diseases: dissectors of the immune system.

Authors:  Rebecca H Buckley
Journal:  Immunol Rev       Date:  2002-07       Impact factor: 12.988

View more
  12 in total

1.  A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.

Authors:  Motoi Yamashita; Ryosuke Wakatsuki; Tamaki Kato; Tsubasa Okano; Shingo Yamanishi; Nobuko Mayumi; Mayuri Tanaka; Yumi Ogura; Hirokazu Kanegane; Shigeaki Nonoyama; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2019-03-08       Impact factor: 2.490

2.  Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.

Authors:  Huie Jing; Qian Zhang; Yu Zhang; Brenna J Hill; Christopher G Dove; Erwin W Gelfand; T Prescott Atkinson; Gulbu Uzel; Helen F Matthews; Peter J Mustillo; David B Lewis; Fotini D Kavadas; I Celine Hanson; Ashish R Kumar; Raif S Geha; Daniel C Douek; Steven M Holland; Alexandra F Freeman; Helen C Su
Journal:  J Allergy Clin Immunol       Date:  2014-05-03       Impact factor: 10.793

3.  IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype.

Authors:  Amy P Hsu; Stefania Pittaluga; Bianca Martinez; Amy P Rump; Mark Raffeld; Gulbu Uzel; Jennifer M Puck; Alexandra F Freeman; Steven M Holland
Journal:  J Clin Immunol       Date:  2015-06-17       Impact factor: 8.317

4.  RAG1 reversion mosaicism in a patient with Omenn syndrome.

Authors:  Elena Crestani; Sharon Choo; Francesco Frugoni; Yu Nee Lee; Stephanie Richards; Joanne Smart; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2014-05-10       Impact factor: 8.317

5.  Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.

Authors:  Yusuke Okuno; Akihiro Hoshino; Hideki Muramatsu; Nozomu Kawashima; Xinan Wang; Kenichi Yoshida; Taizo Wada; Masaharu Gunji; Tomoko Toma; Tamaki Kato; Yuichi Shiraishi; Atsuko Iwata; Toshinori Hori; Toshiyuki Kitoh; Kenichi Chiba; Hiroko Tanaka; Masashi Sanada; Yoshiyuki Takahashi; Shigeaki Nonoyama; Masafumi Ito; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-09-26       Impact factor: 8.317

Review 6.  Partial defects of T-cell development associated with poor T-cell function.

Authors:  Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

Review 7.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

8.  Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.

Authors:  Elina A Tuovinen; Juha Grönholm; Tiina Öhman; Sakari Pöysti; Raine Toivonen; Anna Kreutzman; Kaarina Heiskanen; Luca Trotta; Sanna Toiviainen-Salo; John M Routes; James Verbsky; Satu Mustjoki; Janna Saarela; Juha Kere; Markku Varjosalo; Arno Hänninen; Mikko R J Seppänen
Journal:  J Clin Immunol       Date:  2020-02-19       Impact factor: 8.317

Review 9.  Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.

Authors:  Elena Blanco; Natalia Izotova; Claire Booth; Adrian James Thrasher
Journal:  Front Immunol       Date:  2020-11-27       Impact factor: 7.561

10.  Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency.

Authors:  Yujuan Hou; Hans Peter Gratz; Guillermo Ureña-Bailén; Paul G Gratz; Karin Schilbach-Stückle; Tina Renno; Derya Güngör; Daniel A Mader; Elke Malenke; Justin S Antony; Rupert Handgretinger; Markus Mezger
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.